Free Trial

National HealthCare (NYSEAMERICAN:NHC) Shares Cross Above 200-Day Moving Average - Here's What Happened

National HealthCare logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • National HealthCare shares crossed above their 200-day moving average of $204.40, reaching $234.65 and last trading at $234.48. The company had a $3.67 billion market capitalization and a P/E ratio of 26.38.
  • The company reported quarterly revenue of $408.03 million and earnings of $1.74 per share, while declaring a quarterly dividend of $0.67, equivalent to a 1.1% yield and a $2.68 annualized payout.
  • Insiders sold 17,645 shares worth about $4.0 million over the past 90 days, while institutional ownership stood at 56.44%, including new positions from BlackRock and Morgan Stanley.
  • Five stocks to consider instead of National HealthCare.

National HealthCare Corporation (NYSEAMERICAN:NHC - Get Free Report) passed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $204.40 and traded as high as $234.65. National HealthCare shares last traded at $234.48, with a volume of 80,762 shares traded.

National HealthCare Stock Performance

The company's 50-day moving average price is $224.64 and its 200 day moving average price is $204.40. The stock has a market capitalization of $3.67 billion, a PE ratio of 26.38 and a beta of 0.60.

National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $1.74 earnings per share for the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%. The firm had revenue of $408.03 million for the quarter.

National HealthCare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.67 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $2.68 annualized dividend and a yield of 1.1%. National HealthCare's dividend payout ratio (DPR) is 61.89%.

Insiders Place Their Bets

In other National HealthCare news, CEO Stephen Fowler Flatt sold 1,500 shares of National HealthCare stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $237.08, for a total transaction of $355,620.00. Following the sale, the chief executive officer directly owned 65,487 shares of the company's stock, valued at approximately $15,525,657.96. The trade was a 2.24% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director David R. Gifford sold 1,779 shares of the company's stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $225.42, for a total value of $401,022.18. Following the transaction, the director owned 1,030 shares in the company, valued at $232,182.60. This trade represents a 63.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 17,645 shares of company stock valued at $3,991,668 over the last ninety days. 13.92% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On National HealthCare

Several hedge funds have recently made changes to their positions in NHC. BlackRock Inc. bought a new position in National HealthCare in the second quarter worth $417,602,000. Morgan Stanley Institutional Investment Advisors LLC purchased a new position in National HealthCare during the second quarter valued at $217,391,000. First Trust Advisors LP lifted its position in National HealthCare by 45.4% during the first quarter. First Trust Advisors LP now owns 530,302 shares of the company's stock valued at $84,689,000 after buying an additional 165,615 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of National HealthCare during the 2nd quarter valued at $25,854,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of National HealthCare by 407.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 75,257 shares of the company's stock valued at $12,019,000 after buying an additional 60,420 shares in the last quarter. 56.44% of the stock is currently owned by institutional investors.

National HealthCare Company Profile

(Get Free Report)

National HealthCare Corporation (NHC) is a healthcare services company that provides post-acute and long-term care through a network of skilled nursing centers, rehabilitation facilities, assisted living communities and memory care services. The company also offers home health, hospice and palliative care, behavioral health services, and other related healthcare programs.

NHC serves patients and residents primarily across the southeastern United States. Its services are designed to support individuals recovering from illness or injury, managing chronic conditions, or requiring long-term assistance and residential care.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in National HealthCare Right Now?

Before you consider National HealthCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National HealthCare wasn't on the list.

While National HealthCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines